{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:58:39Z","timestamp":1793120319890,"version":"4.5.0"},"reference-count":55,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Hepatol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>The global burden of hepatitis D virus (HDV) infection represents a major medical challenge and a public health crisis worldwide. However, there is a lack of accurate data on the epidemiology and risk factors for HDV. Hepatitis B virus (HBV) and HDV coinfection causes the most severe form of viral hepatitis, leading to a higher cumulative incidence of liver-related events compared with HBV monoinfection, including the need for liver transplantation and death.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To investigate the epidemiology, natural history, risk factors and clinical management of HBV and HDV coinfection in Romanian patients.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>This prospective study was conducted between January and July 2022 in six tertiary gastroenterology and hepatology referral centres in Romania. All consecutive adults admitted for any gastroenterology diagnosis who were HBV-positive were enrolled. Patients with acute hepatitis or incomplete data were excluded. Of the 25390 individuals who presented with any type of gastroenterology diagnosis during the study period, 963 met the inclusion criteria. Testing for anti-HDV antibodies and HDV RNA was performed for all participants. Demographic and risk factor data were collected by investigators using medical charts and patient questionnaires. All data were stored in an anonymized online database during the study.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>The prevalence of HBV was 3.8%; among these patients, the prevalence of HBV\/HDV coinfection was 33.1%. The median age of the study population was 54.0 years, and it consisted of 55.1% men. A higher prevalence of HBV\/HDV coinfection was observed in patients 50\u201369 years old. Patients with HBV\/HDV coinfection were significantly older than those with HBV monoinfection (P  = 0.03). Multivariate multiple regression analysis identified female gender (P  = 0.0006), imprisonment (P  &lt; 0.0001), older age at diagnosis (P  = 0.01) and sexual contact with persons with known viral hepatitis (P  = 0.0003) as significant risk factors for HDV.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>This study shows that HDV infection among those with HBV remains endemic in Romania and updates our understanding of HDV epidemiology and associated risk factors. It emphasizes the need for systematic screening for HDV infection and collaborative initiatives for controlling and preventing HBV and HDV infection.<\/jats:p>","DOI":"10.4254\/wjh.v16.i4.640","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:56:26Z","timestamp":1713927386000},"page":"640-649","source":"Crossref","is-referenced-by-count":7,"title":["Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update"],"prefix":"10.4254","volume":"16","author":[{"given":"Speranta","family":"Iacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Gheorghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Onica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Huiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina Silvia","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Brisc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Sirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mihaela","family":"Brisc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Diaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Rogoveanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Sandulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiana","family":"Vuletici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Trifan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.09.058"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316601"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.07.005"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323628"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.030"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14357"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/1568010053622867"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21078"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21590"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000795"},{"key":"B14","unstructured":"World Health Organization.   Hepatitis D. Jul 20, 2023. [cited 2 November 2023]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912696"},{"key":"B16","unstructured":"European Medicines Agency.   Hepcludex. [cited 2 November 2023]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/hepcludex"},{"key":"B17","unstructured":"Casa Na\u021bional\u0103 de Asigur\u0103ri de S\u0103n\u0103tate.   Protocoale terapeutice. [cited 2 November 2023]. Available from: https:\/\/cnas.ro\/protocoale-terapeutice\/"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.15403\/jgld.2014.1121.244.dtv"},{"key":"B19","unstructured":"Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, Parvulescu I, Constantinescu I. Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol 2005; 14: 329-335"},{"key":"B20","unstructured":"Grigorescu M, Pascu O, Acalovschi M, Radu C. What is the real prevalence of the D virus infection in chronic hepatitis and liver cirrhosis in Romania? Rom J Gastroenterol 2003; 12: 179-182"},{"key":"B21","unstructured":"National Institute of Public Health Romania.   The National Framework Plan for the viral hepatitis control in Romania, 2019-2030, coordinated by the Ministry of Health Romania. [cited 2 November 2023]. Available from: https:\/\/www.globalhep.org\/about\/partner-programs\/national-framework-plan-viral-hepatitis-control-romania-2019-2030"},{"key":"B22","unstructured":"World Health Organization.   ICD-10. 2019. [cited 2 November 2023]. Available from: https:\/\/icd.who.int\/browse10\/2019\/en"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13310"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328358b0bb"},{"key":"B26","unstructured":"Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis 2010; 19: 373-379"},{"key":"B27","unstructured":"Tahaei SM, Mohebbi SR, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P, Khanyaghma M, Hosseini Razavi A, Sharifian A, Zali MR. Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench 2014; 7: 144-150"},{"key":"B28","unstructured":"Manghisi OG, Guglielmi V, Cozzolongo R, Buongiorno G, Cuppone R, Ragnini F, Pirrelli M, Rosina F. [The risk factors for hepatitis D viral infection in southern Italy]. Minerva Gastroenterol Dietol 1996; 42: 11-16"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104870"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12939"},{"key":"B31","unstructured":"Indaco Lege.   Decretul nr. 770\/1966 pentru reglementarea intreruperii cursului sarcinii. [cited 2 November 2023]. Available from: https:\/\/Lege5.ro\/gratuit\/g43dqmzt\/decretul-nr-770-1966-pentru-reglementarea-intreruperii-cursului-sarcinii"},{"key":"B32","unstructured":"Hepatitis B Foundation.   Vaccination: vaccine non-responders. [cited 16 February 2024]. Available from: https:\/\/www.hepb.org\/prevention-and-diagnosis\/vaccination\/vaccine-non-responders\/"},{"key":"B33","unstructured":"Hepatitis B Foundation.   Vaccine for Hepatitis B. [cited 16 February 2024]. Available from: https:\/\/www.hepb.org\/prevention-and-diagnosis\/vaccination\/"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01329.x"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000954"},{"key":"B38","unstructured":"Bakhshipour A, Mashhadi M, Mohammadi M, Nezam SK. Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Med Iran 2013; 51: 260-264"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2174\/1871526522666220620115006"},{"key":"B40","unstructured":"Diaconu S, Filip P, Tiuca N, Tomescu A, Dugan C.   Preliminary data from the viral hepatitis microelimination project through HCV\/HBV screening in prisoners in Romania [presentation]. Proceedings of the 41st National Congress of Gastroenterology, Hepatology and Digestive Endoscopy; 2023 Jun 7\u201310"},{"key":"B41","unstructured":"Naoumov NV, Gueorgiev A, Ognyanov M, Maleev A. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria. Hepatogastroenterology 1986; 33: 49-51"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13604"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001253"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23653"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/v10070363"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104812"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.35"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14367"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14950"},{"key":"B51","unstructured":"De Ledinghen V, Guyader D, Metivier S, Hilleret M-N, Fontaine H, Roche B, Carrie NG, Alteroche LD, Ratti VL, Gervais A.   Safety and efficacy of 2mg bulevirtide in patients with chronic HBV\/HDV co-infection: first real-world results French early access program. Proceedings of the AASLD: The Liver Meeting; 2021 Nov 13-16; Digital"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213429"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.016"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888"},{"key":"B55","unstructured":"World Health Organization.   Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. [cited 16 February 2024]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/strategies\/global-health-sector-strategies"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i4\/640.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i4\/640.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:06:07Z","timestamp":1713927967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i4\/640.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":55,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4254\/wjh.v16.i4.640","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,27]]}}}